• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代病理学中肿瘤内异质性的检测:多部位肿瘤采样视角

Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.

作者信息

Cortés Jesús M, de Petris Giovanni, López José I

机构信息

Quantitative Biomedicine Unit, Biocruces Research Institute, Barakaldo, Spain; Ikerbasque: The Basque Foundation for Science, Bilbao, Spain; Department of Cell Biology and Histology, University of the Basque Country (UPV/EHU), Leioa, Spain.

Department of Pathology and Laboratory Medicine, Penrose St Francis Hospital , Colorado Springs, CO , USA.

出版信息

Front Med (Lausanne). 2017 Mar 6;4:25. doi: 10.3389/fmed.2017.00025. eCollection 2017.

DOI:10.3389/fmed.2017.00025
PMID:28321395
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5337957/
Abstract

Current sampling protocols of neoplasms along the digestive tract and in the urinary bladder have to be updated, as they do not respond to the necessities of modern personalized medicine. We show here that an adapted version of multisite tumor sampling (MSTS) is a sustainable model to overcome current deficiencies in digestive and bladder tumors when they are large enough so as to make unaffordable a total sampling. The new method is based on the divide-and-conquer algorithm and includes a slight modification of the MSTS, which proved to be useful very recently in clear cell renal cell carcinoma. This analysis confirms the usefulness of MSTS for detecting intratumor heterogeneity (ITH) in tumors arising in hollow viscera. However, MSTS does not seem to improve routine traditional sampling in detecting tumor budding, extramural venous invasion, and perineural invasion. We conclude that (1) MSTS is the best method for tumor sampling to detect ITH balancing high performance and sustainable cost, (2) MSTS must be adapted to tumor shape and tumor location for an optimal performance.

摘要

目前消化道和膀胱肿瘤的采样方案必须更新,因为它们无法满足现代个性化医疗的需求。我们在此表明,当消化道和膀胱肿瘤足够大以至于无法进行全采样时,一种改良版的多部位肿瘤采样(MSTS)是克服当前这些肿瘤采样缺陷的可持续模式。新方法基于分治算法,对MSTS进行了微调,该微调最近在透明细胞肾细胞癌中被证明是有用的。这项分析证实了MSTS在检测中空脏器肿瘤的肿瘤内异质性(ITH)方面的有效性。然而,在检测肿瘤芽生、壁外静脉侵犯和神经周围侵犯方面,MSTS似乎并未改善常规传统采样。我们得出结论:(1)MSTS是检测ITH的最佳肿瘤采样方法,能平衡高性能和可持续成本;(2)MSTS必须根据肿瘤形状和肿瘤位置进行调整以实现最佳性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0908/5337957/9545a35048fd/fmed-04-00025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0908/5337957/83cfd7b8465c/fmed-04-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0908/5337957/9545a35048fd/fmed-04-00025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0908/5337957/83cfd7b8465c/fmed-04-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0908/5337957/9545a35048fd/fmed-04-00025-g002.jpg

相似文献

1
Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.现代病理学中肿瘤内异质性的检测:多部位肿瘤采样视角
Front Med (Lausanne). 2017 Mar 6;4:25. doi: 10.3389/fmed.2017.00025. eCollection 2017.
2
Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).多部位肿瘤采样(MSTS)可提高透明细胞肾细胞癌(CCRCC)肿瘤内异质性组织学检测的性能。
F1000Res. 2016 Aug 17;5:2020. doi: 10.12688/f1000research.9419.2. eCollection 2016.
3
Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.多部位肿瘤取样可增强在肿瘤进展的所有不同时间阶段对肿瘤内异质性的检测。
Virchows Arch. 2018 Feb;472(2):187-194. doi: 10.1007/s00428-017-2223-y. Epub 2017 Aug 25.
4
A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.肿瘤采样中的分而治之策略可提高常规病理学中肿瘤内异质性的检测:透明细胞肾细胞癌的建模方法
F1000Res. 2016 Mar 22;5:385. doi: 10.12688/f1000research.8196.2. eCollection 2016.
5
Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas.迈向透明细胞肾细胞癌的个性化采样
Cancers (Basel). 2022 Jul 12;14(14):3381. doi: 10.3390/cancers14143381.
6
The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.肿瘤生态进化对肾细胞癌样本采集的影响
Cancers (Basel). 2018 Dec 4;10(12):485. doi: 10.3390/cancers10120485.
7
Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.多部位肿瘤采样:一种增强肿瘤内异质性检测的新肿瘤选择方法。
Hum Pathol. 2017 Jun;64:1-6. doi: 10.1016/j.humpath.2017.02.010. Epub 2017 Feb 23.
8
Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.具有侵袭性行为的透明细胞肾细胞癌在组织学水平上显示出低肿瘤内异质性。
Curr Urol Rep. 2022 Jun;23(6):93-97. doi: 10.1007/s11934-022-01095-9. Epub 2022 Apr 13.
9
Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy.程序性死亡配体1(SP-142)免疫组化异质性在透明细胞肾细胞癌免疫治疗中的潜在影响
Pathol Res Pract. 2018 Aug;214(8):1110-1114. doi: 10.1016/j.prp.2018.06.003. Epub 2018 Jun 12.
10
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.高水平的肿瘤内异质性是高级别透明细胞肾细胞癌中上皮-间质转化标志物表达的特征。
Ann Diagn Pathol. 2018 Jun;34:27-30. doi: 10.1016/j.anndiagpath.2018.01.001. Epub 2018 Jan 10.

引用本文的文献

1
Hot Spots in Urogenital Basic Cancer Research and Clinics.泌尿生殖系统基础癌症研究与临床热点
Cancers (Basel). 2025 Mar 31;17(7):1173. doi: 10.3390/cancers17071173.
2
Dynamic Assessment of Tissue and Plasma -Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.采用液滴数字 PCR 分析检测组织和血浆中激活和 T790M 突变,动态评估非小细胞肺癌患者接受 EGFR-TKIs 治疗的反应和耐药情况。
Int J Mol Sci. 2022 Sep 26;23(19):11353. doi: 10.3390/ijms231911353.
3
Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas.

本文引用的文献

1
Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.多部位肿瘤采样:一种增强肿瘤内异质性检测的新肿瘤选择方法。
Hum Pathol. 2017 Jun;64:1-6. doi: 10.1016/j.humpath.2017.02.010. Epub 2017 Feb 23.
2
From tumour heterogeneity to advances in precision treatment of colorectal cancer.从肿瘤异质性到结直肠癌精准治疗的进展。
Nat Rev Clin Oncol. 2017 Apr;14(4):235-246. doi: 10.1038/nrclinonc.2016.171. Epub 2016 Dec 6.
3
The Warburg effect: 80 years on.瓦尔堡效应:80年过去了。
迈向透明细胞肾细胞癌的个性化采样
Cancers (Basel). 2022 Jul 12;14(14):3381. doi: 10.3390/cancers14143381.
4
Intratumor graph neural network recovers hidden prognostic value of multi-biomarker spatial heterogeneity.肿瘤内图神经网络恢复多生物标志物空间异质性的隐藏预后价值。
Nat Commun. 2022 Jul 22;13(1):4250. doi: 10.1038/s41467-022-31771-w.
5
Mutation Profile Variability in the Primary Tumor and Multiple Pulmonary Metastases of Clear Cell Renal Cell Carcinoma. A Review of the Literature and Analysis of Four Metastatic Cases.透明细胞肾细胞癌原发肿瘤与多发肺转移灶的突变谱变异性:文献综述及四例转移病例分析
Cancers (Basel). 2021 Nov 24;13(23):5906. doi: 10.3390/cancers13235906.
6
PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.PRMT1在肾细胞肿瘤中的表达——在鉴别诊断中的应用及预后相关性
Diagn Pathol. 2019 Oct 26;14(1):120. doi: 10.1186/s13000-019-0901-6.
7
The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.肿瘤生态进化对肾细胞癌样本采集的影响
Cancers (Basel). 2018 Dec 4;10(12):485. doi: 10.3390/cancers10120485.
8
Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.多部位肿瘤取样可增强在肿瘤进展的所有不同时间阶段对肿瘤内异质性的检测。
Virchows Arch. 2018 Feb;472(2):187-194. doi: 10.1007/s00428-017-2223-y. Epub 2017 Aug 25.
Biochem Soc Trans. 2016 Oct 15;44(5):1499-1505. doi: 10.1042/BST20160094.
4
The challenges of tumor genetic diversity.肿瘤基因多样性的挑战。
Cancer. 2017 May 15;123(6):917-927. doi: 10.1002/cncr.30430. Epub 2016 Nov 8.
5
MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.微小RNA let-7、T细胞与结直肠癌患者的生存率
Cancer Immunol Res. 2016 Nov;4(11):927-935. doi: 10.1158/2326-6066.CIR-16-0112. Epub 2016 Oct 13.
6
Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).多部位肿瘤采样(MSTS)可提高透明细胞肾细胞癌(CCRCC)肿瘤内异质性组织学检测的性能。
F1000Res. 2016 Aug 17;5:2020. doi: 10.12688/f1000research.9419.2. eCollection 2016.
7
Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.CD44变体9表达作为膀胱癌预后指标的临床意义
Oncol Rep. 2016 Nov;36(5):2852-2860. doi: 10.3892/or.2016.5061. Epub 2016 Sep 1.
8
Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.结直肠癌中肿瘤芽生影响的系统评价和荟萃分析
Br J Cancer. 2016 Sep 27;115(7):831-40. doi: 10.1038/bjc.2016.274. Epub 2016 Sep 6.
9
Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma.转移性尿路上皮癌发展过程中的时空克隆进化。
Mol Oncol. 2016 Nov;10(9):1450-1460. doi: 10.1016/j.molonc.2016.08.003. Epub 2016 Aug 17.
10
A multi-site cutting device implements efficiently the divide-and-conquer strategy in tumor sampling.一种多部位切割装置在肿瘤采样中有效地实施了分而治之策略。
F1000Res. 2016 Jul 6;5:1587. doi: 10.12688/f1000research.9091.2. eCollection 2016.